1 result(s) for RITUXAN
|PI Name||Protocol #||Title|
|Andy Chen||IRB00008906||GO27834: A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of pinatuzumab vedotin (DCDT2980S) in Combination with Rituximab or Polatuzumab Vedotin (DCDS4501A) in Combination with Rituximab and A Non Randomized phase Ib/II Evaluation of Polatuzumab Vedotin in Combination with Obinutuzumab in Patients with Relapsed or Refractory B-cell Cell Non- Hodgkin’s Lymphoma|
You may also qualify for Phase 1 Program trials.
For more information: